Overview:
Preclinical CROs are organizations that provide support to the pharmaceutical and biotechnological in their research endeavor by aiding with outsourced research services. Their service includes testing of bioanalysis pharmacokinetics/pharmacodynamics (PK/PD) or drug metabolism and pharmacokinetics (DMPK), and toxicology. Launching of a product or extensive researches often require a substantial number of experts and factors such as scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Mostly, these different sorts of people with sufficient credentials under one roof are quite unimaginable. Preclinical CRO segment can provide a holistic service by providing access to all the above-mentioned.
The global preclinical contract research organization (CRO) market, as per the report of Market Research Future (MRFR), is all set to grow by an impressive 6.6% CAGR during the forecast period (2018-2023). Preclinical cro industry overview was previously valued at USD 4,450.2 million in 2017.
The preclinical CRO market is all set to benefit from the growing numbers of the life science companies that are investing much in research and development. Many drugs, on the other hand, are now no longer patent-protected, which can push the preclinical CRO market forward. However, the growing production of biosimilars and biologics can hinder the market growth in the coming years.
Regional Analysis:
MRFR in their latest report on the preclinical CRO market included regions such as the Americas, Europe, Asia Pacific (APAC), and the Middle East Africa (MEA) for a better study of the market.
The Americas is holding the maximum share of the global market and is likely to maintain the same state during the forecast period. The region has the superlative infrastructure and maximum exposure to the latest technologies which play well for the regional market growth. The impact gets doubled with the presence of some big investors such as CROs including IQVIA, Charles River, and Laboratory Corporation of America Holdings.
Europe’s market is doing extraordinarily good as key players are getting involved in some strategic moves that include mergers, joint ventures, and acquisition. In August 2017, the Mercachem and Syncom have joined hands and formed the Mercachem-Syncom Group to become the leading mid-sized European CRO which can be considered exemplary. Government initiatives are also commendable owing to which the market can improve substantially.
The APAC market has emerged as a lucrative option for the service-providers as the cost-effective labor in India and China are has grabbed the eyes of the major market players. The huge population base in the region can also provide much traction to the regional market in the coming years.
The MEA market would see moderate growth due to the growing business in the Middle East. The regulatory body of the UAE is helping research and development sector by cooperating extensively which can ensure substantial growth during the forecast period.
Segmentation:
MRFR in their report in the global preclinical CRO market segmented the market by service, therapeutic area, and end-user.
Based on the service, the preclinical CRO market can be segmented into bioanalysis and dystrophia myotonica protein kinase (DMPK) studies, toxicology testing, and others. The toxicology testing segment can lead the market over the forecast period as the rising demand for new drugs is spurring the new product testing.
Based on the therapeutic area, the preclinical CRO market can be segmented into cardiovascular diseases, oncology, diabetes, immunological disorders, infectious diseases, respiratory diseases, and others.
Based on the end user, the preclinical CRO market comprises pharmaceutical biopharmaceutical industries, medical device companies, and others. Growth in biosimilar production and demand for new drugs can substantially promote the pharmaceutical biopharmaceutical segment ahead.
Preclinical CRO Market Players
- PAREXEL International Corporation,
- Envigo,
- Charles River,
- IQVIA,
- ICON plc,
- Eurofins Scientific,
- PRA Health Sciences (PRA),
- Medpace,
- Laboratory Corporation of America Holdings,
- WuXi AppTec,
- Pharmaceutical Product Development,
- LLC,
- MD Biosciences
among others are some key companies in the global Preclinical CRO that are listed by MRFR for market research.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
